NovaLead Pharma commences Phase 3 Clinical Trial of Its Novel Topical Drug Galnobax for DFU
Subject to satisfactory completion of Phase 3 trial, Galnobax can be a path-breaking treatment for Diabetic Foot Ulcer (DFU)
Recover your password.
A password will be e-mailed to you.